APA (7th ed.) Citation

Volpi, S., Ambroni, M., Buzzetti, R., Cimino, G., Gramegna, A., Lucanto, M. C., . . . Braggion, C. (2025). Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study. International Journal of Molecular Sciences, 26(21), 10513. https://doi.org/10.3390/ijms262110513

Chicago Style (17th ed.) Citation

Volpi, Sonia, et al. "Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study." International Journal of Molecular Sciences 26, no. 21 (2025): 10513. https://doi.org/10.3390/ijms262110513.

MLA (9th ed.) Citation

Volpi, Sonia, et al. "Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study." International Journal of Molecular Sciences, vol. 26, no. 21, 2025, p. 10513, https://doi.org/10.3390/ijms262110513.